Meta-hallmarks of aging and cancer
Universidad de Oviedo · Centro de Investigación Biomédica en Red de Cáncer · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
513
total citations
- FWCI
- 91.25
- Percentile
- 100%
- References
- 287
Citations per year
Authors
5- CLCarlos López-Otı́nCorresponding
Universidad de Oviedo, Centro de Investigación Biomédica en Red de Cáncer, Instituto de Investigación Sanitaria del Principado de Asturias
- FPFederico Pietrocola
Karolinska Institutet
- DRDavid Roiz‐Valle
Universidad de Oviedo
- LGLorenzo Galluzzi
Cornell University, Lander Institute
- GKGuido Kroemer
Inserm, Institut Universitaire de France, Université Paris Cité, Institut Gustave Roussy, Sorbonne Université, Centre de Recherche des Cordeliers, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Hôpital Européen
Topics & keywords
Topics
Keywords
- Epigenetics
- Telomere
- Cancer
- Genome instability
- Carcinogenesis
- Biology
- Context (archaeology)
- Senescence
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- BSBristol-Myers Squibb Foundation
- LALeukemia and Lymphoma Society
- APAssociation pour la Recherche sur le Cancer
- “C“la Caixa” FoundationAward: HR17-00221
- FBFundación Bancaria Caja de Ahorros de Asturias
- SFSeerave Foundation
- AEAstraZeneca España
- BIBoehringer Ingelheim España
- ANAgence Nationale de la RechercheAward: UMS3655
- FPFondation pour la Recherche Médicale
- KIKarolinska Institutet
- LCLigue Contre le Cancer
- VVetenskapsrådetAward: VR MH 2019-02050
- IUInstitut Universitaire de France
- MDMinisterio de Ciencia e Innovación
- INInstitut National Du Cancer
- CICancéropôle Ile de France
- NNNovo Nordisk FondenAward: NNF21OC0070086
- NINational Institutes of Health
- WCWeill Cornell Medical College
- SUStand Up To CancerAward: ZP-6177
- WCWeill Cornell Medicine
- EREuropean Research Council
- ARAustralian Research Council
- IDInstituto de Salud Carlos III
- LILabex Immuno-OncologyAward: ANR-18-IDEX-0001
- NCNational Cancer InstituteAwards: 274291, ZP-6177, CA274291, -6177